A panelist discusses how uncomplicated urinary tract infections (UTIs) typically affect otherwise healthy individuals and can be treated with short-course antibiotics by primary care physicians, while ...
Vera Therapeutics' Atacicept has shown promising results in IgA nephropathy, leading to significant stock gains. But read why I'm cautious of entering VERA stock.